Generic medicine
Linezolid
Linezolid · Anti-infectives · Oxazolidinone antibacterials
Data statusRegistration & price fields require source verification.
327brands/products
110companies
327with current prices
Available dosage forms
Tap a form to filter the brand listChoose a form
Pakistan brand index
Available brands
Print / Save PDFAll 327 brands
327 results
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price | Unit price |
|---|---|---|---|---|---|---|---|
| Zoldap | Getz Pharma (Pvt) Limited | 600 mg/300 mL | IV infusion | 300mL | 055433 | PKR 1,221.732026-07-27 | PKR 4.07/ mL |
| Zoldap | Getz Pharma (Pvt) Limited | 100 mg/5 mL | Suspension | 120ml | 104291 | PKR 997.952026-07-27 | PKR 8.32/ mL |
| Zoldap | Getz Pharma (Pvt) Limited | 100 mg/5 mL | Suspension | 60ml | 104291 | PKR 525.242026-07-27 | PKR 8.75/ mL |
| Zoldap | Getz Pharma (Pvt) Limited | 600 mg | Tablet | 10's | 055439 | PKR 4,135.322026-07-27 | PKR 413.53/ tablet |
| Zoldap | Getz Pharma (Pvt) Limited | 400 mg | Tablet | 10's | 055434 | PKR 2,362.762026-07-27 | PKR 236.28/ tablet |
| Zoldap | Getz Pharma (Pvt) Limited | 200 mg/100 mL | IV infusion | 100mL | 055431 | PKR 704.542026-07-27 | PKR 7.05/ mL |
| Zolidean for | himark laboratories (pvt.) Ltd | 100 mg/5 mL | Suspension | 60ml | 112008 | PKR 667.842024-07-01 | PKR 11.13/ mL |
| Zolincid | Focus & Rulz Pharmaceuticals (Pvt) Ltd | 100 mg/5 mL | Dry suspension | 120ml | 116344 | PKR 962.142025-08-22 | PKR 8.02/ mL |
| Zolincid | Focus & Rulz Pharmaceuticals (Pvt) Ltd | 600 mg | Tablet | 12's | 116345 | PKR 3,698.072025-08-22 | PKR 308.17/ tablet |
| Zolincid | Focus & Rulz Pharmaceuticals (Pvt) Ltd | 100 mg/5 mL | Dry suspension | 60ml | 116344 | PKR 506.392025-08-22 | PKR 8.44/ mL |
| Zolinf | RASCO PHARMA | 200 mg/100 mL | IV infusion | 100ml x1's | 078930 | PKR 657.672025-10-02 | PKR 6.58/ mL |
| Zolistat | Standpharm Pakistan Pvt Ltd | 600 mg | Tablet | 12's | 065680 | PKR 4,719.882026-07-27 | PKR 393.32/ tablet |
| Zolistat | Standpharm Pakistan Pvt Ltd | 600 mg/300 mL | IV infusion | 300ml | 094540 | PKR 1,107.952026-07-27 | PKR 3.69/ mL |
| Zolki | High-Q Pharmaceuticals | 600 mg | Tablet | 12's | 114467 | PKR 5,100.012025-08-18 | PKR 425.00/ tablet |
| Zolki | High-Q Pharmaceuticals | 400 mg | Tablet | 10's | 112863 | PKR 2,427.612025-08-18 | PKR 242.76/ tablet |
| Zolki | High-Q Pharmaceuticals | 600 mg | Tablet | 10's | 114467 | PKR 4,250.012025-08-18 | PKR 425.00/ tablet |
| Zolki | High-Q Pharmaceuticals | 100 mg/5 mL | Suspension | 60ml | 112743 | PKR 698.362025-08-18 | PKR 11.64/ mL |
| Zolki | High-Q Pharmaceuticals | 400 mg | Tablet | 12's | 112863 | PKR 2,913.152025-08-18 | PKR 242.76/ tablet |
| Zolki | High-Q Pharmaceuticals | 100 mg/5 mL | Tablet | 120ml | 112743 | PKR 1,326.882025-08-18 | PKR 11.06/ mL |
| Zolrest | Bosch Pharmaceuticals (Pvt) Ltd. | 600 mg/300 mL | IV infusion | 1's | 055916 | PKR 1,258.072026-07-27 | PKR 1,258.07/ vial/unit |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.